A proposed $54 million settlement has been reached in this class action lawsuit regarding the prescription drug Aggrenox® (aspirin/extended-release dipyridamole).  The lawsuit claims that Defendants Boehringer Ingelheim and Teva Pharmaceutical hurt competition and violated state laws by delaying the availability of less-expensive generic versions of Aggrenox®.  Click here for more information.